|
⚲
|
| Keyboard |
| Crosslink Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002067583 |
| Sale | 2026-10-08 (5.5 M Offered, 5.5 M Sold) |
| Fund | |
| Phone | 4048611253 |
| Address | 349351 Newbury Street Boston, MA 02115 |
| Source | [EDGAR] |
| Amount Raised ($M) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-10-20 (D) |
| Exemption | 506(b) |
| Duration | One year or less |
| Revenue | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Cameron Gallagher | Director | |
| David Fallace | Director | |
| Rodolfo Chaparro | Director | |
| Lou Tartaglia | Director | |
| Andrew King | Director | |
| Ronald Seidel III | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Sensata Management Co SCA
✚
|
MA | |
|
Convexity Capital Management LP
✚
|
MA | |
|
Wellesley Bank
✚
|
MA | |
|
Bain Capital Investors LLC
✚
|
MA | |
|
Massachusetts Mutual Life Insurance Company
✚
|
MA | |
|
Colony Group Inc
✚
|
MA | |
|
Berkshire Partners Holdings LLC
✚
|
MA | |
|
Weiss Andrew M
✚
|
MA | |
|
Bennbridge US LLC
✚
|
MA | |
|
Crestfin Capital Partners LLC
✚
|
MA |